Federal Register / Vol. 72, No. 248 / Friday, December 28, 2007 / Notices 73853 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, 

Cooperative Human Tissue Network. 

Date: January 16, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: C. Michael Kerwin, PhD, 

MPH., Scientific Review Administrator, 

Special Review and Logistics Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 6116 Executive Blvd., 

Rm. 8057, Bethesda, MD 20892–8329, 301–

496–7421, kerwinm@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Discovery 

and Development. 

Date: February 6–8, 2008. 

Time: 8 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Peter J. Wirth, PhD, 

Scientific Review Administrator, Research 

Programs Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, 6116 Executive Boulevard, Room 

8131, Bethesda, MD 20892–8328, 301–496–

7565, pw2q@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Advances 

in Protein Expression of Post-Translationally 

Modified Cancer Related Proteins. 

Date: February 28, 2008. 

Time: 12 p.m. to 2 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6130 

Executive Blvd., Conference Room F, 

Rockville, MD 20852 (Telephone Conference 

Call). 

Contact Person: Marvin L. Salin, PhD, 

Scientific Review Administrator, Special 

Review and Logistics Branch, Division of 

Extramural Activities, National Cancer 

Institute, 6116 Executive Boulevard, Room 

7073, Bethesda, MD 20892–8329, 301–496–

0694, msalin@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Innovative 

Technologies for Molecular Analysis of 

Cancer. 

Date: March 5–6, 2008. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crowne Plaza Rockville, 3 Research 

Court, Rockville, MD 20850. 

Contact Person: Jeffrey E. DeClue, PhD, 

Scientific Review Administrator, Special 

Review and Logistics Branch, Division of 

Extramural Activities, National Cancer 

Institute, 6116 Executive Boulevard, Room 

8059, Bethesda, MD 20892–8329, 301–496–

7904, decluej@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: December 19, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–6215 Filed 12–27–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Research 

Resources; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel 

K01–SEP. 

Date: January 15, 2008. 

Time: 12 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892, (Telephone 

Conference Call). 

Contact Person: John R. Glowa, PhD, 

Scientific Review Officer, National Center 

For Research Resources, Or National 

Institutes Of Health, 6701 Democracy Blvd., 

1 Democracy Plaza, Room 1078, MSC 4874, 

Bethesda, MD 20892–4874, 301–435–0807, 

glowaj@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research; 93.371, Biomedical 

Technology; 93.389, Research Infrastructure, 

93.306, 93.333, National Institutes of Health, 

HHS) 

Dated: December 19, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–6214 Filed 12–27–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute On Deafness And 

Other Communication Disorders 

Notice of Meeting. 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Deafness and Other 

Communication Disorders Advisory 

Council. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National 

Deafness and Other Communication 

Disorders Advisory Council. 

Date: January 25, 2008. 

Closed: 8:30 a.m. to 10:45 a.m. 

mstockstill on PROD1PC66 with NOTICES

73854 Federal Register / Vol. 72, No. 248 / Friday, December 28, 2007 / Notices 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Bethesda, 

MD 20892. 

Open: 10:45 a.m. to 2:30 p.m. 

Agenda: Staff reports on divisional, 

programmatic, and special activities. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Bethesda, 

MD 20892. 

Contact Person: Craig A. Jordan, PhD., 

Director, Division of Extramural 

Activities, NIDCD, NIH, Executive Plaza 

South, Room 400C, 6120 Executive 

Blvd., Bethesda, MD 20892–7180, 301–

496–8693, jordanc@nidcd.nih.gov. 

Any interested person may file 

written comments with the committee 

by forwarding the statement to the 

Contact Person listed on this notice. The 

statement should include the name, 

adddress, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for 

entrance onto the NIH campus. All 

visitor vehicles, including taxicabs, 

hotel, and airport shuttles will be 

inspected before being allowed on 

campus. Visitors will be asked to show 

one form of identification (for example, 

a government-issued photo ID, driver’s 

license, or passport) and to state the 

purpose of their visit. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

www.nidcd.nih.gov/about/groups/ 

ndcdac/, where an agenda and any 

additional information for the meeting 

will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.173, Biological Research 

Related to Deafness and Communicative 

Disorders, National Institutes of Health, 

HHS). 

Dated: December 18, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–6184 Filed 12–27–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Deafness and 

Other Communication Disorders; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel; RFP 

Advanced Microelectrode Array. 

Date: January 28, 2008. 

Time: 8 am to 2 pm 

Agenda: To review and evaluate contract 

proposals. 

Place: The Fairmont Washington, DC, 2401 

M Street, NW., Washington, DC 20037. 

Contact Person: Christine A. Livingston, 

PHD, Scientific Review Administrator, 

Division of Extramural Activities, National 

Institutes of Health/NIDCD, 6120 Executive 

Blvd.—MSC 7180, Bethesda, MD 20892, 

(301) 496–8683, livingsc@mail.nih.gov. 

Name of Committee: National Institute of 

Deafness and Other Communication 

Disorders Special Emphasis Panel. 

Date: January 29, 2008. 

Time: 1 pm to 4 pm. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6120 

Executive Blvd., Rockville, MD 20852 

(Telephone Conference Call). 

Contact Person: Sheo Singh, PHD, 

Scientific Review Administrator, Scientific 

Review Branch, Division of Extramural 

Activities, Executive Plaza South, Room 

400C, 6120 Executive Blvd., Bethesda, MD 

20892, 301–496–8683, singhs@nidcd.nih.gov. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel; Research 

Core Center Review. 

Date: January 30, 2008. 

Time: 8 am to 12:30 pm. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont Washington DC., 2401 

M Street, NW., Washington, DC 20037. 

Contact Person: Christine A. Livingston, 

PHD, Scientific Review Administrator, 

Division of Extramural Activities, National 

Institutes of Health/NIDCD, 6120 Executive 

Blvd.—MSC 7180, Bethesda, MD 20892, 

(301) 496–8683, livingsc@mail.nih.gov. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel; Outcomes 

in Children with Mild to Sever Hearing Loss 

Grant Review. 

Date: February 7, 2008. 

Time: 11 am to 1 pm. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6120 

Executive Blvd., Rockville, MD 20852, 

(Telephone Conference Call). 

Contact Person: Christopher Moore, 

Scientific Review Administrator, Division of 

Extramural Activities, National Institutes of 

Health/NIDCD, 6120 Executive Blvd., Rm 

400C, Bethesda, MD 20892–7180, 301–402–

3587, moorechristopher@nidcd.nih.gov. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel; Voice, 

Speech and Language Small Grant Review. 

Date: February 28, 2008. 

Time: 1 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6120 

Executive Blvd., Rockville, MD 20852 

(Telephone Conference Call). 

Contact Person: Sheo Singh, PhD, 

Scientific Review Administrator, Scientific 

Review Branch, Division of Extramural 

Activities, Executive Plaza South, Room 

400C, 6120 Executive Blvd., Bethesda, MD 

20892, 301–496–8683, singhs@nidcd.nih.gov. 

(Catalogue of Federal Domestic 

Assistance Program Nos. 93.173, 

Biological Research Related to Deafness 

and Communicative Disorders, National 

Institutes of Health, HHS) 

Dated: December 18, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–6185 Filed 12–27–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, CEBRA 

Review. 

Date: January 25, 2008. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6101 

Executive Boulevard, Rockville, MD 20852, 

(Virtual Meeting). 

mstockstill on PROD1PC66 with NOTICES